Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antisecretory drugs. Safe and effective?

M J Langman1

  • 1University of Birmingham, Medical School, Queen Elizabeth Hospital.

Drugs
|January 1, 1988
PubMed
Summary

Surveillance of cimetidine (an antisecretory drug) users shows no alarming trends, with mortality rates matching population expectations. However, detecting drug-induced illnesses that mimic common conditions remains a challenge for surveillance studies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Epidemiology of cancer of the large intestine.

Proceedings of the Royal Society of Medicine·2010
Same author

Postmarketing surveillance of the safety of cimetidine: 15-year mortality report.

Pharmacoepidemiology and drug safety·2004
Same author

Which PPI?

Gut·2001
Same author

Ulcer complications associated with anti-inflammatory drug use. What is the extent of the disease burden?

Pharmacoepidemiology and drug safety·2001
Same author

Heparin therapy for ulcerative colitis? Effects and mechanisms.

European journal of gastroenterology & hepatology·2001
Same author

Drug treatment of non-variceal upper gastrointestinal bleeding.

Bailliere's best practice & research. Clinical gastroenterology·2000

Area of Science:

  • Pharmacovigilance
  • Drug Safety Monitoring
  • Gastroenterology

Background:

  • Cimetidine is a widely used antisecretory medication.
  • Drug-induced diseases can present with symptoms similar to common illnesses.
  • Effective surveillance is crucial for identifying potential drug-related adverse events.

Purpose of the Study:

  • To assess the safety profile of cimetidine through surveillance.
  • To evaluate the effectiveness of surveillance in detecting drug-induced illnesses.
  • To determine if cimetidine use is associated with increased mortality or specific disease trends.

Main Methods:

  • Longitudinal surveillance of cimetidine users.
  • Analysis of mortality rates (overall, and for cancer).
  • Comparison of observed trends against population expectations.

Main Results:

  • Surveillance data for cimetidine users has not revealed any disturbing trends.
  • Observed mortality rates in cimetidine users have decreased to match general population expectations.
  • No significant increase in mortality for ordinary diseases or cancer was detected.

Conclusions:

  • The current surveillance pattern for cimetidine is reassuring, suggesting no major drug-induced safety issues are being missed.
  • The study highlights the inherent difficulty in detecting drug-induced illnesses that mimic common community complaints.
  • While reassuring, the low sensitivity of surveillance for subtle, mimicry-based adverse events warrants continued vigilance.

Related Experiment Videos